Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study.

Front Pediatr · 2019 · PMC6514240 · PMID 31134171

Europe PMC DOI

hedged sentence

0.0830

closest p · 1.7× alpha

0.0830

boldest claim

The sentences

showed a trendp = 0.083so close (0.05 < p ≤ 0.1)

In addition, newborns treated with propranolol showed a trend toward a reduced progression to stage 2 (RR 0.855, 95% CI 0.715-1.021; p = 0.083) and to stage 3 without plus (RR 0.724, 95% CI 0.491-1.069; p = 0.104).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.